Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03133104 · ClinicalTrials.gov registry record
Repeat Antenatal Corticosteroids
A clinical trial of Antenatal Corticosteroids, sponsored by St. Louis University.
- Completed
- Registry status
- 182
- Enrollment target
- 1
- Study location
NCT03133104: Completed study of Antenatal Corticosteroids, sponsored by St. Louis University.
NCT03133104 is a study of Antenatal Corticosteroids that has completed, run by St. Louis University. The registered enrollment target is 182 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03133104, a study of Antenatal Corticosteroids, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will review records of women who broke their water early who received a repeat course of antenatal steroids.
Primary Outcome
infant birth weight
Conditions Studied
Interventions
- OTHER Antenatal corticosteroids
Study Locations (1)
Missouri
- St. Mary's Health Center - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2017-01-05 |
| Est. Completion | 2017-08 |
What the finished NCT03133104 record still lists
NCT03133104 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Antenatal Corticosteroids appearing as the primary indexed condition, and to 1 intervention - of which Antenatal corticosteroids is the first listed.
NCT03133104 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03133104 about?
NCT03133104 is a clinical study titled "Repeat Antenatal Corticosteroids". This study will review records of women who broke their water early who received a repeat course of antenatal steroids.
What is the current status of trial NCT03133104?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2017-01-05. Estimated completion is 2017-08.
What conditions does trial NCT03133104 study?
This clinical trial studies the following conditions: Antenatal Corticosteroids.
What interventions are being tested in trial NCT03133104?
The interventions under investigation include: Antenatal corticosteroids (OTHER).
Who is sponsoring clinical trial NCT03133104?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03133104 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI